Trials / Completed
CompletedNCT02472366
A Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Corticosteroid Therapy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Alimera Sciences · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A phase 4 trial evaluating the effect and safety of ILUVIEN in chronic DME patients insufficiently responsive to available therapies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ILUVIEN |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2015-03-01
- Completion
- 2015-05-01
- First posted
- 2015-06-15
- Last updated
- 2015-09-16
- Results posted
- 2015-09-16
Source: ClinicalTrials.gov record NCT02472366. Inclusion in this directory is not an endorsement.